XRCC5 and plasma cell myeloma: The XRCC5 rs1051685 SNP has been associated with susceptibility to myeloma [82], hematologic toxicity in lung cancer patients treated with platinum-based chemotherapy [83], and the prognosis of non-metastasic lung cancer patients [84].